Table 3.
Parameter | Diabetic nephropathy (n = 49) | Hypertensive nephropathy (n = 50) | Polycystic kidney disease (n = 24) | Glomerulo-nephritis (n = 27) | P-value |
---|---|---|---|---|---|
LV diameter index (cm/m2) | 2.6 (0.4) | 2.6 (0.4) | 2.6 (0.4) | 2.7 (0.4) | 0.7 |
LV mass index (g/m2) | 112 (26) | 109 (25) | 109 (27) | 122 (31) | 0.2 |
LA volume index (ml/m2) | 33 (15) | 40 (14) | 31 (12) | 39 (18) | 0.05 |
RV diameter (cm) | 2.7 (0.5) | 2.9 (0.5) | 2.8 (0.5) | 2.8 (0.6) | 0.5 |
LVEF (%) | 54 (12) | 52 (10) | 54 (10) | 54 (9) | 0.9 |
S’lat LV (cm/s) | 7.0 (1.8) | 7.4 (2.4) | 8.3 (2.5) | 8.0 (1.9) | 0.08 |
TAPSE (cm) | 2.0 (0.5) | 2.2 (0.5) | 2.3 (0.6) | 2.3 (0.8) | 0.1 |
S′ RV (cm/s) | 12.3 (2.9) | 12.6 (3.2) | 14.3 (4.1) | 13.0 (3.6) | 0.1 |
PASP (mmHg) | 35 (11) | 36 (14) | 34 (13) | 39 (11) | 0.7 |
TR-gradient (mmHg) | 28 (9) | 30 (12) | 27 (14) | 31 (10) | 0.7 |
Variables are presented as mean (SD) and analyzed by ANOVA
LA denotes left atrium; LV left ventricle, LVEF left ventricular ejection fraction, PASP pulmonic arterial systolic pressure, RV right ventricle, TAPSE tricuspid annular plane systolic excursion, TR tricuspid regurgitation